Daan J. aan de Kerk

A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells

Taco W. Kuijpers, Ester M. M. van Leeuwen, Barbara H. Barendregt et al. · Haematologica · 2013 · 39 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17

Failure To Detect Functional Neutrophil B Helper Cells in the Human Spleen

Sietse Q. Nagelkerke, Daan J. aan de Kerk, Machiel H. Jansen et al. · PLoS ONE · 2014 · 32 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Identification of B Cell Defects Using Age-Defined Reference Ranges for In Vivo and In Vitro B Cell Differentiation

Daan J. aan de Kerk, Machiel H. Jansen, Ineke J. M. ten Berge et al. · The Journal of Immunology · 2013 · 31 citations

Life Sciences, Cell Biology, Immunology +17

High‐throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells

Paul Tuijnenburg, Daan J. aan de Kerk, Machiel H. Jansen et al. · European Journal of Immunology · 2019 · 26 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis

Daan J. aan de Kerk, Ester M. M. van Leeuwen, Machiel H. Jansen et al. · Clinical Immunology · 2013 · 16 citations

Life Sciences, Immunology, Pathology +15